ES2012119A6 - Procedimiento para la produccion de supositorios a base de calcitoninas. - Google Patents

Procedimiento para la produccion de supositorios a base de calcitoninas.

Info

Publication number
ES2012119A6
ES2012119A6 ES8802832A ES8802832A ES2012119A6 ES 2012119 A6 ES2012119 A6 ES 2012119A6 ES 8802832 A ES8802832 A ES 8802832A ES 8802832 A ES8802832 A ES 8802832A ES 2012119 A6 ES2012119 A6 ES 2012119A6
Authority
ES
Spain
Prior art keywords
suppositories
calcitonin
procedure
production
suppository
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8802832A
Other languages
English (en)
Spanish (es)
Inventor
Moise Azria
Michel Steiger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721700A external-priority patent/GB8721700D0/en
Priority claimed from GB888801991A external-priority patent/GB8801991D0/en
Priority claimed from GB888805068A external-priority patent/GB8805068D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2012119A6 publication Critical patent/ES2012119A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
ES8802832A 1987-09-15 1988-09-15 Procedimiento para la produccion de supositorios a base de calcitoninas. Expired - Lifetime ES2012119A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878721700A GB8721700D0 (en) 1987-09-15 1987-09-15 Organic compounds
GB888801991A GB8801991D0 (en) 1988-01-29 1988-01-29 Improvements in/relating to organic compounds
GB888805068A GB8805068D0 (en) 1988-03-03 1988-03-03 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
ES2012119A6 true ES2012119A6 (es) 1990-03-01

Family

ID=27263605

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802832A Expired - Lifetime ES2012119A6 (es) 1987-09-15 1988-09-15 Procedimiento para la produccion de supositorios a base de calcitoninas.

Country Status (26)

Country Link
US (1) US5149537A (OSRAM)
JP (1) JPH01228919A (OSRAM)
KR (1) KR970003052B1 (OSRAM)
AT (1) AT396424B (OSRAM)
AU (1) AU614769B2 (OSRAM)
BE (1) BE1001937A3 (OSRAM)
CA (1) CA1330417C (OSRAM)
CH (1) CH677320A5 (OSRAM)
CY (1) CY1763A (OSRAM)
DE (1) DE3830245A1 (OSRAM)
DK (1) DK509888A (OSRAM)
ES (1) ES2012119A6 (OSRAM)
FI (1) FI87889C (OSRAM)
FR (1) FR2620331B1 (OSRAM)
GB (1) GB2209670B (OSRAM)
HK (1) HK19394A (OSRAM)
HU (1) HU203204B (OSRAM)
IL (1) IL87747A (OSRAM)
LU (1) LU87334A1 (OSRAM)
MY (1) MY103611A (OSRAM)
NL (1) NL8802274A (OSRAM)
NO (1) NO175518C (OSRAM)
NZ (1) NZ226162A (OSRAM)
PH (1) PH24766A (OSRAM)
PT (1) PT88491B (OSRAM)
SE (1) SE8803222L (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013601A1 (en) * 1990-03-15 1991-09-19 Rhône-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
ID29632A (id) 1998-07-24 2001-09-06 Seo Hong Yoo Pembuatan bentuk-bentuk dosis larutan bening berair dengan asam-asam empedu
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
KR100848344B1 (ko) * 2000-02-04 2008-07-25 유서홍 담즙산 함유 청정 수용액 제형의 제조
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
EP2316473B1 (en) 2003-07-23 2013-08-21 Novartis AG Use of calcitonin in osteoarthritis
ATE458489T1 (de) * 2004-08-30 2010-03-15 Seo Hong Yoo Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
JP2008516977A (ja) * 2004-10-15 2008-05-22 セオ ホン ユー 薬剤学的化合物の毒性を減少させるための方法及び組成物
KR101358078B1 (ko) * 2004-11-01 2014-02-06 주식회사 유스팜인터내셔널 근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
KR102287352B1 (ko) * 2015-06-30 2021-08-06 (주)아모레퍼시픽 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH211204A (de) * 1938-12-13 1940-08-31 Chem Ind Basel Verfahren zur Herstellung einer Suppositoriengrundmasse.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
DE3068743D1 (en) * 1980-01-16 1984-08-30 Weder Hans G Process and dialysis-installation for the preparation of bilayer-vesicles and their use
JPS56118013A (en) * 1980-02-25 1981-09-16 Teijin Ltd Calcitonin pharmaceutical and its preparation
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
FI884191A0 (fi) 1988-09-13
MY103611A (en) 1993-08-28
SE8803222D0 (sv) 1988-09-13
SE8803222L (sv) 1989-03-16
KR890004680A (ko) 1989-05-09
FR2620331A1 (fr) 1989-03-17
AT396424B (de) 1993-09-27
HK19394A (en) 1994-03-18
NO884053D0 (no) 1988-09-13
US5149537A (en) 1992-09-22
NL8802274A (nl) 1989-04-03
NZ226162A (en) 1991-03-26
JPH01228919A (ja) 1989-09-12
PH24766A (en) 1990-10-01
DK509888D0 (da) 1988-09-13
FR2620331B1 (fr) 1991-11-08
NO175518C (no) 1994-10-26
PT88491A (pt) 1988-10-01
NO884053L (no) 1989-03-16
GB2209670B (en) 1991-05-08
GB8821429D0 (en) 1988-10-12
FI884191L (fi) 1989-03-16
HUT47864A (en) 1989-04-28
CY1763A (en) 1994-07-15
DE3830245A1 (de) 1989-03-30
KR970003052B1 (ko) 1997-03-14
AU2217588A (en) 1989-04-20
CA1330417C (en) 1994-06-28
ATA224788A (de) 1993-01-15
FI87889B (fi) 1992-11-30
GB2209670A (en) 1989-05-24
PT88491B (pt) 1992-11-30
DK509888A (da) 1989-03-16
NO175518B (no) 1994-07-18
BE1001937A3 (fr) 1990-04-17
LU87334A1 (fr) 1989-07-07
IL87747A (en) 1992-05-25
FI87889C (fi) 1993-03-10
IL87747A0 (en) 1989-02-28
CH677320A5 (OSRAM) 1991-05-15
AU614769B2 (en) 1991-09-12
HU203204B (en) 1991-06-28

Similar Documents

Publication Publication Date Title
ES2012119A6 (es) Procedimiento para la produccion de supositorios a base de calcitoninas.
ES2005499A6 (es) Vidrio en hojas descalinizado y procedimiento para su fabricacion.
ES8604249A1 (es) Un procedimiento para preparar pseudomonato de calcio cris- talino o un hidrato del mismo
FR2633929B2 (fr) Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
AU1668283A (en) Sodium metasilicate
IT7928019A0 (it) Procedimento per la produzione d'acido metacrilico e catalizzatore in esso impiegato.
DK413785A (da) Ekspektorationsmiddel
IT8220323A0 (it) Agente per ridurre la quantita' di acqua in un cemento riducendo anche la quantita' di aria.
IT8024827A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia.
IT1092150B (it) Procedimento per la produzione di oggetti di carbonio o grafite con elevata solidita'
IT1219892B (it) Derivati dell' acido furanuronico,loro preparazione e loro impiego come medicamenti
SE8700137D0 (sv) Diuretisk komposition
ES8506548A1 (es) Un metodo de formacion de un producto de vidrio o ceramica
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
IT1237519B (it) Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
MY102526A (en) Liquid cleanser composition
AR246496A1 (es) Una composicion de aluminio-silicato de metal alcalino, metodo para obtenerla y articulo de fabricacion que contiene a dicha composicion.
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
BR8405277A (pt) Processo para manufatura de um po detergente
ES2015896B3 (es) Sal de una morfolina sustituida con acido fluoborico y agente para la proteccion de la madera.
DE3762121D1 (de) Alkalische gipsmischung mit guarderivaten.
SE8704240D0 (sv) Analgesic preparations
ES8703811A1 (es) Procedimiento de preparacion de un tripolifosfato de sodio
DE3483318D1 (de) Lorazepam-haltiges schlafmittel.
ES2012326A4 (es) Monoesteres del acido griseolico, su preparacion y empleo

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-09-15

FD1A Patent lapsed

Effective date: 20001204